BRPI0810203A2 - Compostos peptídeos cíclicos. - Google Patents

Compostos peptídeos cíclicos.

Info

Publication number
BRPI0810203A2
BRPI0810203A2 BRPI0810203-1A2A BRPI0810203A BRPI0810203A2 BR PI0810203 A2 BRPI0810203 A2 BR PI0810203A2 BR PI0810203 A BRPI0810203 A BR PI0810203A BR PI0810203 A2 BRPI0810203 A2 BR PI0810203A2
Authority
BR
Brazil
Prior art keywords
cyclic peptide
peptide compounds
compounds
cyclic
peptide
Prior art date
Application number
BRPI0810203-1A2A
Other languages
English (en)
Inventor
Toshio Yamanaka
Hidenori Ohki
Junya Ishida
Ayako Toda
Yu Harayama
Takuya Makino
Shigeki Kunikawa
Hiroaki Mizuno
Hiroaki Ohtake
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007902312A external-priority patent/AU2007902312A0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0810203A2 publication Critical patent/BRPI0810203A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0810203-1A2A 2007-05-02 2008-04-25 Compostos peptídeos cíclicos. BRPI0810203A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007902312A AU2007902312A0 (en) 2007-05-02 New Cyclic Peptide Compounds
PCT/JP2008/058456 WO2008139986A1 (en) 2007-05-02 2008-04-25 New cyclic peptide compounds

Publications (1)

Publication Number Publication Date
BRPI0810203A2 true BRPI0810203A2 (pt) 2014-10-14

Family

ID=39671779

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810203-1A2A BRPI0810203A2 (pt) 2007-05-02 2008-04-25 Compostos peptídeos cíclicos.

Country Status (14)

Country Link
US (1) US8603975B2 (pt)
EP (2) EP2150269B1 (pt)
JP (1) JP5459545B2 (pt)
KR (1) KR20100017547A (pt)
CN (1) CN101687012A (pt)
AU (1) AU2008250254B2 (pt)
BR (1) BRPI0810203A2 (pt)
CA (1) CA2684557A1 (pt)
ES (1) ES2396170T3 (pt)
IL (1) IL201485A0 (pt)
MX (1) MX2009011512A (pt)
RU (1) RU2436795C2 (pt)
TW (1) TW200911839A (pt)
WO (1) WO2008139986A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011003259A (es) * 2008-09-24 2011-04-21 Astellas Pharma Inc Compuesto de peptido y metodo para producir el mismo.
SG173180A1 (en) 2009-01-30 2011-09-29 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
SG11201601274QA (en) 2013-08-26 2016-03-30 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
WO2016073480A1 (en) 2014-11-03 2016-05-12 Enanta Pharmaceuticals, Inc. Novel cyclosporin analogues for preventing or treating hepatitis c infection
CN112661808B (zh) * 2020-12-23 2022-05-27 浙江大学 一种酯肽类化合物及其制备方法和应用
WO2024206136A1 (en) * 2023-03-24 2024-10-03 Gilead Sciences, Inc. Process for preparing bulevirtide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Fr901459物質、その製法及び用途
PT1091975E (pt) * 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
AR031010A1 (es) 2000-10-19 2003-09-03 Fujisawa Pharmaceutical Co Una composicion farmaceutica, util para inhibir el dano celular
ES2310604T3 (es) * 2001-10-19 2009-01-16 Isotechnika, Inc. Mezclas de analogos de ciclosporinas y su uso como agentes inmunomoduladores.
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) * 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd C型肝炎治療剤
JP5139065B2 (ja) 2004-10-01 2013-02-06 スシネキス インク C型肝炎感染の治療及び予防のための3−エーテル及び3−チオエーテル置換シクロスポリン誘導体
UA88484C2 (ru) 2004-10-01 2009-10-26 Дебиофарм Са ПРИМЕНЕНИЕ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ВКЛЮЧАЕТ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИН
US7696167B2 (en) * 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound
CA2623898C (en) * 2005-10-26 2013-12-24 Astellas Pharma Inc. New cyclic peptide compounds

Also Published As

Publication number Publication date
WO2008139986A1 (en) 2008-11-20
AU2008250254A1 (en) 2008-11-20
ES2396170T3 (es) 2013-02-19
JP5459545B2 (ja) 2014-04-02
RU2436795C2 (ru) 2011-12-20
EP2150269A1 (en) 2010-02-10
CN101687012A (zh) 2010-03-31
JP2010526024A (ja) 2010-07-29
US20100120672A1 (en) 2010-05-13
CA2684557A1 (en) 2008-11-20
TW200911839A (en) 2009-03-16
MX2009011512A (es) 2009-11-12
EP2455098A1 (en) 2012-05-23
EP2150269B1 (en) 2012-11-21
AU2008250254B2 (en) 2012-08-16
US8603975B2 (en) 2013-12-10
KR20100017547A (ko) 2010-02-16
RU2009144538A (ru) 2011-06-10
IL201485A0 (en) 2010-05-31

Similar Documents

Publication Publication Date Title
DK2041123T3 (da) Kondenserede cykliske forbindelser.
BRPI0815717A2 (pt) Compostos de imidazopirazina.
HRP20151058T1 (xx) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
CL2007002783S1 (es) Inhalador multidosis.
BRPI0813235A2 (pt) Combinação anti-helmíntica.
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
FR2909857B1 (fr) Endovalve.
NL2000581A1 (nl) Aangecondenseerde fenylamidoheterocyclische verbindingen.
DK3354267T3 (da) Stabiliseret sulforaphan
CL2008000208S1 (es) Calzado.
BRPI0814736A2 (pt) inalador.
CL2008000209S1 (es) Calzado.
CL2008001289S1 (es) Calzado.
IL201485A0 (en) New cyclic peptide compounds
BRPI0912716A2 (pt) composto.
FR2922904B1 (fr) Seche-linge.
IT1396642B1 (it) Statore.
FR2924132B1 (fr) Seche-linge.
DK2081952T3 (da) Peptider
BRPI0820409A2 (pt) Composto de polipeptídeo
ITCE20060002A1 (it) Patok.
FR2914850B1 (fr) Deambulateur.
ITPA20070017A1 (it) Ciottola.
ES1066367Y (es) Posavasos.
NL1033607A1 (nl) Bouwwerk.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]